HRS Guidelines Bundle (free trial)

Evaluation and Management of Arrhythmic Risk in Neuromuscular Disorders

Heart Rhythm Society GUIDELINES Apps brought to you free pf charge, courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1499527

Contents of this Issue

Navigation

Page 28 of 49

29 Management strategies Key points • Acute management included brain magnetic resonance imaging and computed tomography to evaluate the presumptive transient ischemic attack; empiric anticoagulation was initiated, as intracerebral hemorrhage and other contraindications were absent. • CMR and EP testing with programmed ventricular stimulation were performed to assess myocardial involvement and conduction system disease, and to determine ventricular arrhythmic risk. The patient may be a candidate for a primary prevention ICD with pacing capability, if significant conduction disease or VAs are observed. • Because the patient was young and otherwise functional with presumptive transient ischemic attack, long-term management included anticoagulation, in the absence of contraindications, with periodic assessment of left ventricular function and surveillance for brady- or tachyarrhythmias. • EDMD is associated with chamber dilation, especially atrial. • AF and atrial standstill with an increased risk of thromboembolic complications including stroke in EDMD are well known. • Low-normal LVEF with AV valve incompetence may reflect mild left ventricular dysfunction in this context. • A directed assessment of arrhythmic risk is warranted in this patient population based on presenting symptoms, physical findings, and clinical index of suspicion for serious rhythm disturbances.

Articles in this issue

Archives of this issue

view archives of HRS Guidelines Bundle (free trial) - Evaluation and Management of Arrhythmic Risk in Neuromuscular Disorders